Quince Therapeutics' Charles Ryan to Depart; Receives $1.014M Severance
Quince Therapeutics' President Charles Ryan departed effective September 8, 2026, under a Separation Agreement providing a $1,014,489.04 lump-sum severance payment.Original SEC Filing: Quince Therapeutics, Inc. [ QNCX ] - 8-K - Sep. 14, 2026This is an AI-powered summary. It may contain inaccuracies…